Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroendocrine Tumors × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 34 Pancreatic Neoplasms 14 Breast Neoplasms 13 Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Rectal Neoplasms 10 Triple Negative Breast Neoplasms 9 Nasopharyngeal Carcinoma 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Uterine Cervical Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 7 Small Cell Lung Carcinoma 6 Sarcoma 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 NSCLC 4 Endometrial Neoplasms 4 Recurrence 3 Glioma 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Thymoma 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2

Interventions

lutetium Lu 177 dotatate 10 Everolimus 5 lanreotide 4 gallium Ga 68 dotatate 4 Magnetic Resonance Spectroscopy 4 177Lu-octreotide, DOTA(0)-Tyr(3)- 4 olaparib 3 amino-acid, glucose, and electrolyte solution 3 Somatostatin 3 Nivolumab 3 Lutetium-177 3 Cyclophosphamide 3 Capecitabine 3 surufatinib 2 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 copper dotatate CU-64 2 cabozantinib 2 Temozolomide 2 Specimen Handling 2 Octreotide 2 Lutetium 2 Injections 2 Fluorodeoxyglucose F18 2 talazoparib 1 sintilimab 1 repotrectinib 1 lenvatinib 1 guarana powder 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡